(adapted from Mavericks of Medicine by David Jay Brown) Raphael Mechoulam, Ph.D., is the Lionel Jacobson Professor of Medicinal Chemistry at the Hebrew University of Jerusalem, where he has been working on cannabinoid chemistry (a term he coined) for more than forty years. Dr. Mechoulam is recognized as one of the world’s experts on cannabinoid-based […]
Omega-3 fatty acid supplements, but not statin drugs, can help patients with chronic heart failure, show two parallel studies conducted for the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico Heart Failure (GISSI-HF) trial and released for early online publication in the Lancet August 31, 2008. Omega-3s’ positive outcomes are especially important since few […]
ADRs seen at 10 mg dose typically used with L-dopa to treat Parkinson’s disease It has been brought to our attention that deprenyl has been associated with ADRs at the higher doses (10 mg/day) typically used when it is taken in conjunction with L-dopa for the treatment of Parkinson’s disease, although not at the low […]
by David Jay Brown, Author of Mavericks of Medicine: Conversations with Creative and Controversial Thinkers who are Changing the Future of Medicine, Smart Publications Marios Kyriazis, M.D., is both a clinician and a researcher in the field of anti-aging medicine. He has made significant contributions in the science and application of anti-aging medicine, and he […]
Abstract In Part I of this article, evidence from a wide range of peer-reviewed research, including in vitro and in vivo studies, clinical and randomized controlled trials, epidemiological studies, meta-analyses and reviews, was presented. The case was made that while decreased chronic disease incidence is clearly associated with generous dietary intake of vitamin E (mixed […]
